140
Participants
Start Date
February 1, 2023
Primary Completion Date
January 30, 2024
Study Completion Date
January 30, 2024
silodosin 8 mg capsule and the pyridostigmine bromide 60 mg tablet
The participants were assigned to groups A and B. Group B received the 8 mg silodosin capsule. In contrast, Group A was administered the silodosin 8 mg capsule and the pyridostigmine bromide 60 mg tablet. Over a week, each group administered their designated drug once per day
silodosin 8 mg capsule
The participants were assigned to groups A and B. Group B received the 8 mg silodosin capsule. In contrast, Group A was administered the silodosin 8 mg capsule and the pyridostigmine bromide 60 mg tablet. Over a week, each group administered their designated drug once per day
Beni-Seuf University Hospital, Banī Suwayf
Beni-Suef University
OTHER